Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024

by
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024

Zanidatamab demonstrated a median overall survival (OS) of 15.5 months in patients with centrally confirmed immunohistochemistry (IHC) 2+ or 3+ and a median OS of 18.1 months in patients with IHC 3+ tumors With approximately two years of median follow-up, as of July 28, 2023, median duration of response (DOR) increased by two months from initial … Read more

How this UK-based firm is growing a more sustainable cannabis

by
How this UK-based firm is growing a more sustainable cannabis

Cannabis plants grow in the clone room at Aurora Deutschland GmbH, a manufacturer of medical Cannabis products, in Leuna, Germany September 11, 2023. Lisi Niesner | Reuters Growing cannabis indoors uses a lot of energy, obviously resulting in higher emissions. But some companies are trying to combat that like U.K.-based cultivator Glass Pharms. It claims … Read more